Abstract:Ethnopharmacological relevance: Salvia plebeia R. Brown, a traditional Chinese medicinal herb, has been used to treat inflammatory diseases such as cough, hepatitis, and diarrhea for a long history. Aim of the study: The aim of the present study was to isolate and identify potential anti-inflammatory agents from the herb of S. plebeia, which may have contributed to its folk pharmacological use in the treatment of inflammatory diseases. Material and methods: The aerial parts of S. plebeia were extracted with 95% ethanol and separated by silica gel, RP-C-18, Sephadex LH-20, and HPLC. The structures of the isolated compounds were elucidated by extensive spectroscopic analysis (MS, NMR, and X-ray). Anti-inflammatory activities of all compounds were evaluated by the model of LPS-induced up-regulated of NO in Raw264.7 macrophages. The expression levels of cytokine (TNF-alpha) and proteins (iNOS and COX-2) were assessed by ELISA kit and Western blotting analysis, respectively. Furthermore, the influences of salviplenoid A (1) on NF-kappa B and MAPK signaling pathways were determined by Western blotting analysis and immunofluorescence assay. Results: Six new (1 - 6, salviplenoids A-F) and ten known (7-16) sesquiterpenoids were isolated from the herb of S. plebeia. The absolute configurations of compounds 1, 2, and 7 were determined by X-ray diffraction. The new eudesmane-type sesquiterpenoid, salviplenoid A (1), significantly decreased the release of NO and TNF-a and the expression of proteins iNOS and COX-2. In addition, the biochemical mechanistic study indicated that 1 regulated the NF-kappa B dependent transcriptional activity through inhibiting the nuclear translocation of p50/p65 dimer and decreasing the phosphorylation of I kappa B and Erk1/2. Conclusions: Among all sesquiterpenoids isolated from S. plebeian, the new salviplenoid A (1) exhibited the most potent anti-inflammatory activity in LPS-induced Raw264.7 cells via inhibition of NF-kappa B and Erk1/2 signaling pathways.

Four New Eudesmane-Type Sesquiterpenes from the Basal Leaves of Salvia Plebeia R. Br.

Three New Eudesmane Sesquiterpenoids and a New Dimer from the Aerial Part of Salvia Plebeia R. Br.

Diterpenoids from Saliva Plebeia R. Br. and Their Antioxidant and Anti-Inflammatory Activities

Bioactive Terpenoids from Salvia Plebeia: Structures, No Inhibitory Activities, and Interactions with Inos

Analysis of Chemical Constituents in Ethanol Extracts from Whole Plant of Salvia Plebeia

Anti-inflammatory Sesquiterpenoids from the Traditional Chinese Medicine Salvia Plebeia: Regulates Pro-Inflammatory Mediators Through Inhibition of NF-κB and Erk1/2 Signaling Pathways in LPS-induced Raw264.7 Cells.

Three New Sesquiterpene Lactones from Inula Britannica

Bioactive Diterpenoids and Sesquiterpenoids with Different Skeletons from Salvia Digitaloides Diels

Bioactive seco-abietane rearranged diterpenoids from the aerial parts of Salvia prionitis.

Three New Diterpenoids from Salvia Przewalskii Maxim

Sesquiterpenoids from Saussurea laniceps.

Eudesmane-Type Sesquiterpenes from Senecio Ambraceus

Neo-clerodane and Abietane Diterpenoids with Neurotrophic Activities from the Aerial Parts of Salvia Leucantha Cav.

Two New Terpenoids and Other Constituents from Salvia Cavaleriei and Their Antibacterial Activities

Eudesmane sesquiterpenoids with inhibitory effects on NO production from Artemisia princeps

Structurally Diverse Diterpenoids from the Roots of Salvia Deserta Based on Nine Different Skeletal Types.

Salviprzols A and B, C21- and C22-terpenoids from the Roots of Salvia Przewalskii Maxim

Two New Diterpenoid Quinones with Lung Protective Activity from the Roots of Salvia Miltiorrhiza

Diterpenoid Quinones from the Salvia Miltiorrhiza and Their Lung Protective Activity.

Sesquiterpenoids from Chloranthus Henryi and Their Anti‐neuroinflammatory Activities

New Sesquiterpenes from Sonchus Transcaspicus